Differences between nitrates: role of isosorbide 2-mononitrate (original) (raw)
Organic nitrates and tolerance in cardiovascular diseases: effects of isosorbide-2-mononitrate compared to traditional nitrates
Giorgio Caretta
Heart International, 2007
View PDFchevron_right
Mechanisms of action of nitrates
Johan Ahlner
Cardiovascular Drugs and Therapy, 1994
View PDFchevron_right
Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of K ATP
Ferenc Fülöp, Saviana Nedeianu, Tibor Pali
British Journal of Pharmacology, 1999
View PDFchevron_right
Effects of nitric oxide synthase inhibitors, l-NG-nitroarginine and l-NG-nitroarginine methyl ester, on responses to vasodilators of the guinea-pig coronary vasculature
Marika Väli
British Journal of Pharmacology, 1992
View PDFchevron_right
The 2 nitrate 1 3 dibuthoxypropan anewnitricoxidedonor induces
Petrônio Athayde Filho
View PDFchevron_right
Clinical Mechanisms of Nitrate Action
Stephen Glasser
The American Journal of Cardiology, 1998
View PDFchevron_right
NO − Activates Soluble Guanylate Cyclase and K v Channels to Vasodilate Resistance Arteries
Joanne Hart
Hypertension, 2003
View PDFchevron_right
Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta
Angel Cogolludo
British Journal of Pharmacology, 1999
View PDFchevron_right
The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms
Barbara Kemp-harper, Kaiyee Chin, Owen Woodman
British Journal of Pharmacology, 2014
View PDFchevron_right
The questionable role of cyclic guanosine 3′ : 5′-monophosphate in heart
Joel Linden
Biochemical Pharmacology, 1979
View PDFchevron_right
Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction
Andreas Daiber
Vascular pharmacology, 2014
View PDFchevron_right
Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats
Yuliya Mikhed
Vascular pharmacology, 2015
View PDFchevron_right
The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature
Joanne Hart
Cardiovascular Research, 2007
View PDFchevron_right
Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide
umair Haider
2010
View PDFchevron_right
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae
Barbara Kemp-harper
Hypertension, 2007
View PDFchevron_right
Analysis of responses to glyceryl trinitrate and sodium nitrite in the intact chest rat
Bobby Nossaman
Nitric Oxide, 2012
View PDFchevron_right
BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts
TURHAN DOST
European Heart Journal, 2009
View PDFchevron_right
Guanylate-cyclase-mediated inhibition of cardiac I Ca by carbachol and sodium nitroprusside
claudia penna
Pflugers Archiv-european Journal of Physiology, 1994
View PDFchevron_right
Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide andnitroxyl ion
Chris Triggle
British Journal of Pharmacology, 2001
View PDFchevron_right
Mechanisms Underlying Relaxation of Rabbit Aorta by Bay 41-2272, a Nitric Oxide-Independent Soluble Guanylate Cyclase Activator
Gilberto De Nucci
Clinical and Experimental Pharmacology and Physiology, 2005
View PDFchevron_right
The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat
Thais Ribeiro
European Journal of Pharmacology, 2012
View PDFchevron_right
Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse
Gautam Sikka
Hypertension, 2015
View PDFchevron_right